GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Heidelberg Pharma AG (LTS:0QW5) » Definitions » PS Ratio

Heidelberg Pharma AG (LTS:0QW5) PS Ratio : 13.17 (As of Dec. 14, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Heidelberg Pharma AG PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Heidelberg Pharma AG's share price is €2.41. Heidelberg Pharma AG's Revenue per Share for the trailing twelve months (TTM) ended in Aug. 2024 was €0.18. Hence, Heidelberg Pharma AG's PS Ratio for today is 13.17.

The historical rank and industry rank for Heidelberg Pharma AG's PS Ratio or its related term are showing as below:

LTS:0QW5' s PS Ratio Range Over the Past 10 Years
Min: 2.93   Med: 15.27   Max: 105.66
Current: 12.91

During the past 13 years, Heidelberg Pharma AG's highest PS Ratio was 105.66. The lowest was 2.93. And the median was 15.27.

LTS:0QW5's PS Ratio is ranked worse than
59.21% of 1015 companies
in the Biotechnology industry
Industry Median: 8.73 vs LTS:0QW5: 12.91

Heidelberg Pharma AG's Revenue per Sharefor the three months ended in Aug. 2024 was €0.03. Its Revenue per Share for the trailing twelve months (TTM) ended in Aug. 2024 was €0.18.

Warning Sign:

Heidelberg Pharma AG revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue per Share Growth Rate of Heidelberg Pharma AG was -9.40% per year. During the past 3 years, the average Revenue per Share Growth Rate was -9.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was 8.10% per year. During the past 10 years, the average Revenue per Share Growth Rate was -9.90% per year.

During the past 13 years, Heidelberg Pharma AG's highest 3-Year average Revenue per Share Growth Rate was 33.40% per year. The lowest was -59.20% per year. And the median was -19.60% per year.

Back to Basics: PS Ratio


Heidelberg Pharma AG PS Ratio Historical Data

The historical data trend for Heidelberg Pharma AG's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heidelberg Pharma AG PS Ratio Chart

Heidelberg Pharma AG Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.53 18.31 95.93 11.51 13.02

Heidelberg Pharma AG Quarterly Data
Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.13 13.02 15.69 14.10 13.72

Competitive Comparison of Heidelberg Pharma AG's PS Ratio

For the Biotechnology subindustry, Heidelberg Pharma AG's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Heidelberg Pharma AG's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Heidelberg Pharma AG's PS Ratio distribution charts can be found below:

* The bar in red indicates where Heidelberg Pharma AG's PS Ratio falls into.



Heidelberg Pharma AG PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Heidelberg Pharma AG's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=2.41/0.183
=13.17

Heidelberg Pharma AG's Share Price of today is €2.41.
Heidelberg Pharma AG's Revenue per Share for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.18.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Heidelberg Pharma AG  (LTS:0QW5) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Heidelberg Pharma AG PS Ratio Related Terms

Thank you for viewing the detailed overview of Heidelberg Pharma AG's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Heidelberg Pharma AG Business Description

Traded in Other Exchanges
Address
Gregor-Mendel-Street 22, Ladenburg, DEU, 68526
Heidelberg Pharma AG is a biopharmaceutical company. It is focused on oncology and develops the toxin Amanitin into cancer therapies using its proprietary Antibody Targeted Amanitin Conjugate (ATAC) technology platform and advances the biological mode of action of the toxin as a novel therapeutic principle. The proprietary lead candidate is HDP-101 which is a BCMA (B-cell maturation antigen) - ATAC for multiple myeloma. In addition, the company offers preclinical contract research services. It operates through the following business divisions: Customer Specific Research, Diagnostics, and TherapeuticS.

Heidelberg Pharma AG Headlines

No Headlines